Journal ArticleOPEN ACCESS

Reversible Dementia Due to Thalidomide Therapy for Multiple Myeloma

  • Morgan A
  • Smith W
  • Levenson J
New England Journal of Medicine (2003) 348(18) 1821-1822
DOI: 10.1056/nejm200305013481822
19Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

Abstract

To the Editor: Thalidomide is used to treat multiple myeloma because of its apoptotic1 and antiangiogenic2 properties. Common side effects of thalidomide in patients with multiple myeloma include s...

Cite

CITATION STYLE

APA

Morgan, A. E., Smith, W. K., & Levenson, J. L. (2003). Reversible Dementia Due to Thalidomide Therapy for Multiple Myeloma. New England Journal of Medicine, 348(18), 1821–1822. https://doi.org/10.1056/nejm200305013481822

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free